Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

A new study reveals that genetic technology can identify male infertility causes, enhancing IVF decisions and reducing ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine ...

What it gets wrong is the birthdate part. Strip away the idea that your sign is based on your birthday — and, instead, swap ...

I’ve always wondered whether I have it in me to get properly ripped. I come from a family of big people – I was never sporty growing up, but have since willed myself into a consistent gym routine as ...

Researchers at UC San Francisco have devised a method to identify pneumonia — using both genetic information and AI — that ...

QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...

DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment practices, house dust mite disease emerging drugs, market share of individual ...

The human brain is often compared to a computer, but the latest wave of research shows it is closer to a self-building city, ...

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing ...